SEC Form 4 research

BioXcel Therapeutics, Inc. insider transactions

Issuer	BioXcel Therapeutics, Inc.
Tickers	BTAI
Reporting owners	35
Officers and directors	8
Last public filing	2026-08-15

Recent insider disclosures

Available	Trade date	Reporting owners	Code	Shares	Price	Reported value
2026-08-14	2026-08-12	Atkins Susan E.	A	17,000	$0	Not reported

Officers and directors in the directory

Yocca Frank — 27 qualifying
Rodriguez Javier — 9 qualifying
Steinhart Richard I — 16 qualifying
Mehta Vimal — 52 qualifying
MUELLER PETER — 129 qualifying
Nandabalan Krishnan — 9 qualifying
O'Neill Vincent — 21 qualifying
Wiley Matthew T. — 7 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.